Hematopoietic growth factor inducible neurokinin-1 (Gpnmb/Osteoactivin) is a biomarker of progressive renal injury across species

Kidney International

Volumn 79, Issue 10, 2011, Pages 1138-1148

  Patel Chamberlin, Mina ^a   Wang, Ying ^a   Satirapoj, Bancha ^a   Phillips, Lynetta M ^a   Nast, Cynthia C ^b   Dai, Tiane ^a   Watkins, Renecia A ^a   Wu, Xiwei ^c   Natarajan, Rama ^c   Leng, Aishe ^a   Ulanday, Kathleene ^a   Hirschberg, Raimund R ^a   Lapage, Janine ^a   Nam, Edouardo J ^a   Haq, Tahmina ^a   Adler, Sharon G ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

chronic kidney disease; diagnosis; proteinuria; renal injury

Indexed keywords

BIOLOGICAL MARKER; CREATININE; DIURETIC AGENT; HEMATOPOIETIC GROWTH FACTOR INDUCIBLE NEUROKININ 1; IMMUNOSUPPRESSIVE AGENT; LOSARTAN; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CELL INFILTRATION; CELL MEMBRANE; CELL TRANSPORT; CELLULAR DISTRIBUTION; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOPLASM VESICLE; DIABETIC NEPHROPATHY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FREEZING; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; INTERSTITIAL NEPHRITIS; KIDNEY CORTEX; KIDNEY INJURY; KIDNEY INTERSTITIUM; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE; LUPUS ERYTHEMATOSUS NEPHRITIS; LYSOSOME; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; RAT; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; TUBULAR ATROPHY; URINALYSIS;

EID: 79955625516     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.28     Document Type: Article

References (52)

1. Bandari PS, Qian J, Yehia G et al. Hematopoietic growth factor inducible neurokinin-1 type: a transmembrance protein that is similar to neurokinin-1 interacts with substance P. Requl Pept 2003; 111: 169-178. (Pubitemid 36254765)
2. Safadi FF, Xu J, Smock SL et al. Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts. J Cell Biochem 2001; 84: 12-26. (Pubitemid 33101507)
3. Owen TA, Smock SL, Prakash S et al. Identification and characterization of the genes encoding human and mouse osteoactivin. Crit Rev Eukaryot Gene Expr 2003; 13: 205-220. (Pubitemid 38009170)
4. Sheng MH-C, Wergedal JE, Mohan S et al. Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity. FEBS Lett 2008; 582: 1451-1458.
5. Weterman MA, Ajubi N, van Dinter IM et al. nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts. Int J Cancer 1995; 60: 73-81.
6. Nikawa T, Ishidoh K, Hirasaka K et al. Skeletal muscle gene expression in space-flown rats. FASEB J 2004; 18: 522-524.
7. Bächner D, Schrö der D, Gross G. mRNA expression of the murine glycoprotein (transmembrane) nmb (Gpnmb) gene is linked to the developing retinal pigment epithelium and iris. Gene Expr Patterns 2002; 1: 159-165.
8. Ahn JH, Lee Y, Jeon C et al. Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis. Blood 2002; 100: 1742-1754. (Pubitemid 34925153)
9. Abdelmagid SM, Barbe MF, Rico MC et al. Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function. Exp Cell Res 2008; 314: 2334-2351.
10. Selim AA. Osteoactivin bioinformatic analysis: prediction of novel functions, structural features, and modes of action. Med Sci Monit 2009; 15: MT19-MT33.
11. Nowlin BT, Ichimura T, Lin S-L et al. Reparative macrophages and injured epithelia express Gpnmb, a novel autophagosome associated glycoprotein which directs phagocytic trafficking for degradation and reveals convergence of autophagic and phagocytic pathways. JASN 2008; 19: 85A.
12. Kharasch ED, Schroeder JL, Bammler T et al. Gene expression profiling of nephrotoxicity from the sevoflurane degradation product fluoromethyl- 2,2-difluoro-1-(trifluoromethyl)vinyl ether ('compound A') in rats. Toxicol Sci 2006; 90: 419-431.
13. Rodwell GEJ, Sonu R, Zahn JM et al. A transcriptional profile of aging in the human kidney. PLOS Biol 2004; 2: 2189-2210.
14. Schmid H, Boucherot A, Yasuda Y et al. Modular activation of nuclear factor-{kappa} B transcriptional programs in human diabetic nephropathy. Diabetes 2006; 55: 2993-3003. (Pubitemid 44923635)
15. Nakamura A, Ishii A, Ohata C et al. Early induction of osteoactivin expression in rat renal tubular epithelial cells after unilateral ureteral obstruction. Exp Toxicol Pathol 2007; 59: 53-59. (Pubitemid 47225211)
16. Ihm CG, Lee GS, Nast CC et al. Early increased renal procollagen alpha 1(IV) mRNA levels in streptozotocin induced diabetes. Kidney Int 1992; 41: 768-777.
17. Dai T, Natarajan R, Nast CC et al. Glucose and diabetes: effects on podocyte and glomerular p38MAPK, heat shock protein 25, and actin cytoskeleton. Kidney Int 2006; 69: 806-814.
18. Adler SG, Kang SW, Feld S et al. Can glomerular mRNAs in human type 1 diabetes be used to predict transition from normoalbuminuria to microalbuminuria? Am J Kidney Dis 2002; 40: 184-188. (Pubitemid 34701227)
19. Adler SG, Kang SW, Feld S et al. Glomerular mRNAs in human type 1 diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy. Kidney Int 2001; 60: 2330-2336. (Pubitemid 33070476)
20. Kasahara K, Nakayama Y, Nakazato Y et al. Src signaling regulates completion of abscission in cytokinesis through ERK/MAPK activation at the midbody. J Biol Chem 2007; 282: 5327-5339. (Pubitemid 47093765)
21. Kuan CT, Wakiya K, Dowell JM et al. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme. Clin Cancer Res 2006; 12: 1970-1982.
22. Furochi H, Tamura S, Mameoka M et al. Osteoactivin fragments produced by ectodomain shedding induce MMP-3 expression via ERK pathway in mouse NIH-3T3 fibroblasts. FEBS Lett 2007; 581: 5743-5750. (Pubitemid 350235424)
23. Hoashi T, Sato S, Yamaguchi Y et al. Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein. FASEB J 2010; 24: 1616-1629.
24. Qian X, Mills E, Torgov M et al. Pharmacologically enhanced expression of GPNMB increases the sensitivity of melanoma cells to the CR011-vcMMAE antibody-drug conjugate. Mol Oncol 2008; 2: 81-93.
25. Rose AA, Annis MG, Dong Z et al. ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties. PLoS ONE 2010; 5: e12093.
26. He J, Tohyama Y, Yamamoto K et al. Lysosome is a primary organelle in B cell receptor-mediated apoptosis: an indispensable role of Syk in lysosomal function. Genes Cells 2005; 10: 23-35. (Pubitemid 40352615)
27. Bonnerot C, Briken V, Amigorena S. Intracellular signaling and endosomal trafficking of immunoreceptors: shared effectors underlying MHC class IIrestricted antigen presentation. Immunol Lett 1997; 57: 1-4.
28. Majeed M, Caveggion E, Lowell CA et al. Role of Src kinases and Syk in Fcgamma receptor-mediated phagocytosis and phagosome-lysosome fusion. J Leukoc Biol 2001; 70: 801-811. (Pubitemid 33127015)
29. Abtahian F, Bezman N, Clemens R et al. Evidence for the requirement of ITAM domains but not SLP-76/Gads interaction for integrin signaling in hematopoietic cells. Mol Cell Biol 2006; 26: 6936-6949. (Pubitemid 44387642)
30. Zou W, Kitaura H, Reeve J et al. Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J Cell Biol 2007; 176: 877-888. (Pubitemid 46425547)
31. Ulanova M, Puttagunta L, Marcet-Palacios M et al. Syk tyrosine kinase participates in beta1-integrin signaling and inflammatory responses in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2005; 288: L497-L507. (Pubitemid 40229515)
32. Jakus Z, Fodor S, Abram CL et al. Immunoreceptor-like signaling by beta 2 and beta 3 integrins. Trends Cell Biol 2007; 17: 493-501.
33. Arany I, Megyesi JK, Kaneto H et al. Cisplatin-induced cell death is EGFR/ src/ERK signaling dependent in mouse proximal tubule cells. Am J Physiol Renal Physiol 2004; 287: F543-F549. (Pubitemid 39095970)
34. Duta F, Ulanova M, Seidel D et al. Differential expression of spleen tyrosine kinase Syk isoforms in tissues: effects of the microbial flora. Histochem Cell Biol 2006; 126: 495-505. (Pubitemid 44435906)
35. Waanders F, Vaidya VS, van Goor H et al. Effect of renin- angiotensinaldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial. Am J Kid Dis 2009; 53: 16-25.
36. Oberbauer R. Biomarkers - a potential route for improved diagnosis and management of ongoing renal damage. Transplant Proc 2008; 40(10 Suppl): S44-S47.
37. Bolignano D, Lacquaniti A, Coppolino G et al. Neutrophil gelatinase associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 337-344.
38. Kamijo A, Sugaya T, Hikawa A et al. Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem 2006; 284: 175-182. (Pubitemid 44404425)
39. Li B, Castano A, Hudson TE et al. The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair. FASEB J 2010; 24: 4767-4781.
40. Bohle A, Mackensen-Haen S, von Gise H. Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: a morphometric contribution. Am J Nephrol 1987; 7: 421-433. (Pubitemid 18025635)
41. Nath K. The tubulointerstitium in progressive kidney disease. Kidney Int 1998; 54: 992-994.
42. Gilbert RE, Cooper ME. More than an aftermath of glomerular injury. Kidney Int 1999; 56: 1627-1637.
43. Gerritsma JS, van Kooten C, Gerritsen AF et al. Transforming growth factor-beta 1 regulates chemokine and complement production by human proximal tubular epithelial cells. Kidney Int 1998; 53: 609-616. (Pubitemid 28124274)
44. Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of progressive renal disease. Kidney Int 1997; 51: 2-15. (Pubitemid 27064516)
45. Yanagita M, Okuda T, Endo S et al. Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury. J Clin Invest 2006; 116: 70-79. (Pubitemid 43121792)
46. Toma I, Kang JJ, Sipos A et al. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J Clin Invest 2008; 118: 2526-2534. (Pubitemid 351949780)
47. Cachat F, Lange-Sperandio B, Chang AY et al. Ureteral obstruction in neonatal mice elicits segment-specific tubular cell responses leading to nephron loss. Kidney Int 2003; 63: 564-575. (Pubitemid 36126802)
48. Mori KH, Lee T, Rapoport D et al. Endocytic delivery of lipocalinsiderophore- iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005; 115: 610-621. (Pubitemid 40322235)
49. Kuwabara T, Mori K, Mukoyama M et al. Urinary neutrophil gelatinase associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons: source and changes of urinary Ngal in renal injury. Kidney Int 2009; 75: 285-294.
50. Lee GS, Nast CC, Peng SC et al. Differential response of glomerular epithelial and mesangial cells after subtotal nephrectomy. Kidney Int 1998; 53: 1389-1398. (Pubitemid 28316903)
51. Ichimura T, Hung CC, Yang SA et al. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol 2004; 286: F552-F563. (Pubitemid 38233650)
52. Zhou H, Yuen PS, Pisitkun T et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int 2006; 69: 1471-1476.